Matching slides 78,138
Current window 55,801-55,830
Pages 2,605
Rows per page 30
Component: Chartclear collectionreset all

Component

55,801-55,830 of 78,138

filter-aware
05
The chart uses a gradient area fill to emphasize growth over time.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 36 slides · Apollo
Conference presentation Investment bank Beat · Situation & ContextLoop · Benchmark Gap1 hit
14
The slide uses a comparison frame to highlight Athene's superior financial position relative to peers.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Problem & Complication1 hit
36
The slide uses a comparative bar chart structure to highlight Athene's superior performance across three key financial dimensions.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Evidence & Proof1 hit
07
The chart shows a positive correlation between IgG reduction and clinical improvement in MG-ADL scores.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations Beat · Rising Success1 hit
05
The slide uses a three-column structure: current portfolio, historical performance chart, and future pipeline.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
13
The slide lists 6 points (5R + digital), though the title refers to the 5R framework.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
14
The slide uses a stacked bar chart to compare AstraZeneca (first bar) against five competitors (R, P, N, J, M).AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
18
The slide uses a three-column layout to present project metrics, chemical safety improvements, and biological efficacy results.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
19
The slide uses a combination of process flow, microscopy imagery, and a bar chart to demonstrate the therapeutic potential of HVP cells.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
23
The slide uses a color-coded grid to distinguish between highlighted pipeline assets and others, with extensive footnotes detailing specific drug mechanisms and disease targets.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
26
The slide uses a Gantt-style chart to visualize the compression of development phases.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
29
The slide uses a three-column layout to present product features, scientific data, and clinical trial status.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
49
The slide uses a timeline framework to demonstrate clinical efficacy over time.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
50
The chart shows revenue split between US and Ex-US markets.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
64
The slide uses a combination of a biological pathway diagram and a violin plot to demonstrate drug efficacy.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
80
The slide uses a color-coded legend to distinguish highlighted presentation items from other pipeline medicines.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
22
The slide uses a process diagram to show production and a combination of anatomical illustration and a line chart to show the mechanism of action and therapeutic effect.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Timeline1 hit
24
The slide uses a comparison framework to contrast the pharmacokinetic profile of recombinant cytokines (spiky) vs RiboCytokines (sustained).BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations 1 hit
28
The chart uses a stacked bar to decompose total revenue into four distinct categories, with a bracket highlighting the COVID-19 specific portion.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Appendix Data1 hit
15
The chart is a classic waterfall-bridge diagram illustrating the financial flow of a capitated contract.Cano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank Beat · SolutionLoop · Before After1 hit
17
Uses red 'X' icons to emphasize negative industry challenges.Cano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
19
The chart shows a stacked bar comparison between 2019 and 2025, with CAGR annotations for both total Medicare and MA segments.Cano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank Loop · Cost Of Inaction1 hit
20
Cano Health | SPAC Presentation Deck | 77 slidesCano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank Beat · AgitateLoop · Cost Of Inaction1 hit
23
The slide uses a before-after style comparison between national benchmarks and Cano Health performance.Cano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank 1 hit
24
The chart uses a stacked bar format to visualize age segments, with a summary metric for average age at the bottom.Cano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank 1 hit
25
The chart demonstrates that Cano Health consistently serves a population with higher chronic condition prevalence than the MA average.Cano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank 1 hit
26
The chart demonstrates a consistent reduction in medical claims expense ratios for longer-tenured members across all four listed chronic conditions.Cano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank 1 hit
27
The chart demonstrates that longer-tenured members have significantly lower medical claims expense ratios.Cano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank 1 hit
28
The chart illustrates that as the number of chronic conditions increases, the medical claims expense ratio generally increases.Cano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank 1 hit
29
The chart illustrates an inverse relationship between member age and medical claims expense ratio.Cano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank 1 hit